基于网络药理学探讨辣椒抗乳腺癌的潜在机制
Exploring the Potential Mechanism of Capsicum against Breast Cancer Based on Network Pharmacology
DOI: 10.12677/TCM.2023.123108, PDF,   
作者: 董小蓉, 张甜甜, 周 刚:三峡大学健康医学院,湖北 宜昌;三峡大学中医医院/宜昌市中医医院,湖北 宜昌
关键词: 网络药理学辣椒乳腺癌潜在机制Network Pharmacology Capsicum Breast Cancer Mechanism
摘要: 目的:基于网络药理学探讨辣椒抗乳腺癌的潜在作用机制。方法:在TCMSP数据库中筛选辣椒的活性化合物;利用PubChem和SwissTargetPrediction预测辣椒活性化合物的靶点基因;利用Genecards和OMIM数据库筛选疾病的靶点;利用Cytoscape 3.9.1软件构建药物–成分–靶点的可视化网络;通过STRING数据库对关键靶点构建蛋白质相互作用(PPI)网络;利用David数据库进行GO功能以及KEGG通路富集分析。结果:辣椒活性化合物共14个,药物靶点基因为270个;乳腺癌疾病靶点基因1280个;辣椒–乳腺癌共同靶点基因76个;KEGG通路富集分析显示辣椒可参与调控与乳腺癌相关的多条通路,包括P13K-AKT信号通路、HIF-1信号通路、Fox0信号通路以及Prolactin信号通路等肿瘤经典通路。结论:辣椒可能通过多个靶点、多个通路发挥抗乳腺癌的作用。
Abstract: Objective: To investigate the potential mechanism of capsicum against breast cancer based on network pharmacology. Methods: The active compounds of capsicum were screened in the TCMSP database; PubChem and SwissTargetPrediction were used to predict target genes of active compounds in capsicum; Screening targets for disease using the Genecards and OMIM databases; Cytoscape 3.9.1 software was used to build a drug-component-target visualization network; Protein interaction (PPI) networks were constructed for key targets through the STRING database; The David database was used for GO functionality and KEGG pathway enrichment analysis. Results: There were 14 active compounds in capsicum pepper, and 270 drug target genes. 1280 breast cancer disease target genes; 76 capsicum-breast cancer co-target genes; KEGG pathway enrichment analysis showed that pepper can participate in the regulation of multiple pathways related to breast cancer, including P13K-AKT signaling pathway, HIF-1 signaling pathway, Fox0 signaling pathway, and Prolactin signaling pathway and other tumor classical pathways. Conclusion: Capsicum may exert anti-breast cancer effects through multiple targets and multiple pathways.
文章引用:董小蓉, 张甜甜, 周刚. 基于网络药理学探讨辣椒抗乳腺癌的潜在机制[J]. 中医学, 2023, 12(3): 710-719. https://doi.org/10.12677/TCM.2023.123108

参考文献

[1] Katsura, C., Ogunmwonyi, I., Kankam, H.K., et al. (2022) Breast Cancer: Presentation, Investigation and Management. British Journal of Hospital Medicine (London), 83, 1-7. [Google Scholar] [CrossRef] [PubMed]
[2] 2020年全球癌症最新数据解读[J]. 中国肿瘤临床与康复, 2021, 28(3): 301.
[3] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[4] Shahbandi, A., Nguyen, H.D. and Jackson, J.G. (2020) TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines. Trends Cancer, 6, 98-110. [Google Scholar] [CrossRef] [PubMed]
[5] Wu, J., Gao, H., Ge, W., et al. (2020) Over Expression of PTEN Induces Apoptosis and Prevents Cell Proliferation in Breast Cancer Cells. Acta Biochimica Polonica, 67, 515-519. [Google Scholar] [CrossRef] [PubMed]
[6] Lima, Z.S., Ghadamzadeh, M., Arashloo, F.T., et al. (2019) Recent Advances of Therapeutic Targets Based on the Molecular Signature in Breast Cancer: Genetic Mutations and Implications for Current Treatment Paradigms. Journal of Hematology Oncology, 12, 38. [Google Scholar] [CrossRef] [PubMed]
[7] Feng, Y., Spezia, M., Huang, S., et al. (2018) Breast Cancer Development and Progression: Risk Factors, Cancer Stem Cells, Signaling Pathways, Genomics, and Molecular Pathogenesis. Genes & Diseases, 5, 77-106. [Google Scholar] [CrossRef] [PubMed]
[8] Lolas, H.S., Renbaum, P., Kamal, L., et al. (2017) Genomic Analysis of Inherited Breast Cancer among Palestinian Women: Genetic Heterogeneity and a Founder Mutation in TP53. International Journal of Cancer, 141, 750-756. [Google Scholar] [CrossRef] [PubMed]
[9] De Cicco, P., Catani, M.V., Gasperi, V., et al. (2019) Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence. Nutrients, 11, 1514. [Google Scholar] [CrossRef] [PubMed]
[10] Youn, H.J. and Han, W. (2020) A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors. The Asian Pacific Journal of Cancer Prevention, 21, 867-880. [Google Scholar] [CrossRef
[11] Chlebowski, R.T., Aragaki, A.K. anderson, G.L., et al. (2020) Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women’s Health Initiative Randomized Trial. Journal of Clinical Oncology, 38, 1419-1428. [Google Scholar] [CrossRef
[12] Mohd, H.N., Yusof, N.A., Yahaya, A.F., et al. (2019) Carotenoids of Capsicum Fruits: Pigment Profile and Health- Promoting Functional Attributes. Antioxidants (Basel), 8, 469. [Google Scholar] [CrossRef] [PubMed]
[13] 吴璐瑶, 乔立娟. 我国城乡居民辣椒消费现状及趋势分析[J]. 中国瓜菜, 2022, 35(8): 109-113.
[14] 畅立圣, 陈红宇, 张莹瑄, 等. 基于网络药理学探讨辣椒抗大肠癌的潜在作用机制[J]. 上海中医药大学学报, 2022, 36(S1): 204-209.
[15] Hernandez-Perez, T., Gomez-Garcia, M., Valverde, M.E., et al. (2020) Capsicum annuum (Hot Pepper): An Ancient Latin-American Crop with Outstanding Bioactive Compounds and Nutraceutical Potential. A Review. Comprehensive Reviews in Food Science and Food Safety, 19, 2972-2993. [Google Scholar] [CrossRef] [PubMed]
[16] Yang, L., Sun, J., Zhao, M., et al. (2022) Chili Pepper Intake and All-Cause and Disease-Specific Mortality. International Journal for Vitamin and Nutrition Research. [Google Scholar] [CrossRef] [PubMed]
[17] Baskaran, P., Covington, K., Bennis, J., et al. (2018) Binding Efficacy and Thermogenic Efficiency of Pungent and Nonpungent Analogs of Capsaicin. Molecules, 23, 3199. [Google Scholar] [CrossRef] [PubMed]
[18] Hu, X., Saravanakumar, K., Jin, T., et al. (2021) Effects of Yellow and Red Bell Pepper (Paprika) Extracts on Pathogenic Microorganisms, Cancerous Cells and Inhibition of Survivin. Journal of Food Science and Technology, 58, 1499-1510. [Google Scholar] [CrossRef] [PubMed]
[19] Chou, C.C., Wu, Y.C., Wang, Y.F., et al. (2009) Capsaicin-Induced Apoptosis in Human Breast Cancer MCF-7 Cells through Caspase-Independent Pathway. Oncology Reports, 21, 665-671.
[20] Xie, Z.Q., Li, H.X., Hou, X.J., et al. (2022) Capsaicin Suppresses Hepatocarcinogenesis by Inhibiting the Stemness of Hepatic Progenitor Cells via SIRT1/SOX2 Signaling Pathway. Cancer Medicine, 11, 4283-4296. [Google Scholar] [CrossRef] [PubMed]
[21] Chen, C., Zhang, M., Zheng, X., et al. (2022) Association between Chili Pepper Consumption and Risk of Gastrointestinal-Tract Cancers: A Meta-Analysis. Frontiers in Nutrition, 9, Article ID: 935865. [Google Scholar] [CrossRef] [PubMed]
[22] Lei, J., Wang, Q., Li, G., et al. (2021) beta-Caryophyllene from Chilli Pepper Inhibits the Proliferation of Non-Small Cell Lung Cancer Cells by Affecting miR-659-3p-Targeted Sphingosine Kinase 1 (SphK1). International Journal of General Medicine, 14, 9599-9613. [Google Scholar] [CrossRef
[23] 毛岸云, 陈茂剑, 覃庆洪, 等. 辣椒碱通过下调SIRT1表达抑制乳腺癌MCF-7细胞的迁移和侵袭[J]. 中国实验方剂学杂志, 2019, 25(7): 94-99.
[24] 陈茂剑, 蒋玮, 毛岸云, 等. 辣椒碱对乳腺癌MDA-MB-231细胞裸鼠移植瘤生长的抑制作用[J]. 中国实验方剂学杂志, 2019, 25(7): 82-88.
[25] Adami, E.R., Corso, C.R., Turin-Oliveira, N.M., et al. (2018) Antineoplastic Effect of Pectic Polysaccharides from Green Sweet Pepper (Capsicum annuum) on Mammary Tumor Cells in Vivo and in Vitro. Carbohydrate Polymers, 201, 280-292. [Google Scholar] [CrossRef] [PubMed]
[26] 网络药理学评价方法指南[J]. 世界中医药, 2021, 16(4): 527-532.
[27] 张石蕾, 刘佳丽, 龚福恺, 等. 基于网络药理学和实验验证探讨肉苁蓉防治癌因性疲劳的作用机制研究[J]. 中国中药杂志, 2023, 48(5): 1330-1342.
[28] Trayes, K.P. and Cokenakes, S. (2021) Breast Cancer Treatment. American Family Physician, 104, 171-178.
[29] 秦娟, 宋冬. 乳腺癌不同时期治疗方式的研究进展[J]. 医学理论与实践, 2022, 35(12): 2023-2025.
[30] 中国抗癌协会乳腺癌诊治指南与规范(2019年版) [J]. 中国癌症杂志, 2019, 29(8): 609-680.
[31] 贾朋邵, 程旭锋, 马士豪, 等. 中医药治疗巩固期乳腺癌用药规律[J]. 中医学报, 2022, 37(12): 2707-2712.
[32] 刘胜, 孙霃平. 乳腺癌中医文献溯源考[C]//中华中医药学会. 2011年中医外科学术年会论文集. 2011: 118-121.
[33] 陈慧心, 李子欣, 黄莹莹, 等. 中医药治疗乳腺癌相关性抑郁研究进展[J]. 实用中医内科杂志, 2022, 36(12): 19-21.
[34] Dunneram, Y., Greenwood, D.C. and Cade, J.E. (2019) Diet, Menopause and the Risk of Ovarian, Endometrial and Breast Cancer. Proceedings of the Nutrition Society, 78, 438-448. [Google Scholar] [CrossRef
[35] Lee, J.E. (2021) Diet before and after Breast Cancer. In: Noh, D.-Y., Han, W. and Toi, M., Eds., Translational Research in Breast Cancer, Advances in Experimental Medicine and Biology, Vol. 1187, Springer, Berlin, 545-566. [Google Scholar] [CrossRef] [PubMed]
[36] Li, Y., Li, S., Meng, X., et al. (2017) Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients, 9, Article No. 728. [Google Scholar] [CrossRef] [PubMed]
[37] 陈茂剑, 杨伟萍, 覃庆洪, 等. 辣椒碱对乳腺癌MCF-7细胞增殖及p21和FBI-1表达的影响[J]. 中国实验方剂学杂志, 2018, 24(22): 102-106.
[38] Chen, M., Xiao, C., Jiang, W., et al. (2021) Capsaicin Inhibits Proliferation and Induces Apoptosis in Breast Cancer by Down-Regulating FBI-1-Mediated NF-kappaB Pathway. Drug Design, Development and Therapy, 15, 125-140. [Google Scholar] [CrossRef
[39] 李伯和, 袁磊. 辣椒碱对乳腺癌MDA-MB-231细胞迁移和侵袭的抑制作用及其机制[J]. 生理学报, 2017, 69(2): 183-188.
[40] Li, Z., Song, Y., Hou, W., et al. (2022) Atractylodin Induces Oxidative Stress-Mediated Apoptosis and Autophagy in Human Breast Cancer MCF-7 Cells through Inhibition of the P13K/Akt/mTOR Pathway. Journal of Biochemical and Molecular Toxicology, 36, e23081. [Google Scholar] [CrossRef] [PubMed]